Close this search box.

Pirfenidone Tablet

Pirfenidone Tablet

Active substance -: Pirfenidone Tablet
Strength -: 200mg, 267mg, 801mg

Available Brand Names for “Pirfenidone Tablet” In India

Available Brands Manufacturer / Marketer
Pulmofib 200mg Tablet MSN
Pulmofib 267mg Tablet MSN
Pulmofib 801mg Tablet MSN

Procedure for Delivery Request:
For more information on products or how to order you can submit an online request or reach us on the given contact details, we will get back to you shortly.

We distribute a diverse range of pharmaceutical drugs, catering to the entirety of the pharmaceutical trade, which includes wholesale, tender supplies, orphan drugs, named patient access, biologics, biosimilars, and vaccines.

For Overseas Patient / Export Inquires.

Alleviare specialize in delivering pharmaceutical supplies domestically and internationally. With a customer base exceeding 250 satisfied clients across 65 countries at competitive prices. For your next order of generic drugs, please reach out to us.

Call Us

+91 9643240915 (Mr. Yashpal Singh) +91 9289711087 (Ms. Sana Sadyar)


+91 9643240915 (Mr. Yashpal Singh) +91 9289711087 (Ms. Sana Sadyar)

Email Us

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.


Pirfenidone Tablet: Indications

Pirfenidone is used for the treatment of idiopathic pulmonary fibrosis (scarring of the lungs with an unknown cause). Pirfenidone is in a class of medications called pyridones. It works by blocking the action of a certain natural substance in the body that is involved in causing fibrosis.

Pirfenidone Tablet – Drug Information

Drug : Pirfenidone
Pharmacological Classification: Anti-fibrotics or Anti-inflammatory agents
Therapeutic Indication: Mild to moderate Idiopathic Pulmonary Fibrosis
Dosage Forms:Tablet
Hsn Code: 30049099


Additional information


1. Genentech, Inc. Efficacy and Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (IPF) (ASCEND). NIH U.S. National Library of Medicine [Revised in April 2017] [Accessed on 18th June 2022]

2. Paul W. Noble, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. du Bois, Elizabeth A. Fagan, Robert S. Fishman, Ian Glaspole, Marilyn K. Glassberg, Lisa Lancaster, David J. Lederer, Jonathan A. Leff, Steven D. Nathan, Carlos A. Pereira, Jeffrey J. Swigris, Dominique Valeyre, and Talmadge E. King, Jr. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials. NIH. National Library of Medicine, National center for biotechnology information. January 2016. [Accessed on 18th June 2022]

3. Roche Products Limited. Electronic Medicines Compendium (EMC). [Revised in February 2022] [Accessed on 18th June 2022]

4. InterMune, Inc. U.S. Food & Drug Administration. [Revised in October 2014] [Accessed on 18th June 2022]

5. Roche Pharma AG. European Medical Agency (EMA). [Revised in September 2015] [Accessed on 18th June 2022]

6. Hoffmann-La Roche Limited. Pirfenidone. [Revised in August 2021] [Accessed on 18th June 2022]

About Us

Alleviare Life Sciences private limited India, specializes in the Global Export of all Specialty Drugs, including Vaccines & Cold Chain Pharma Products, and General Pharmaceutical Products to our customers. We don’t process requests for Schedule X and other habit-forming drugs.

We also provide consulting services to Indian patients for medicines that are not available/registered in India. Assisting patients with documentation, logistics and procurement of such medicines from international authorised suppliers/distributors.

We are also present globally as marketing & distribution company, operating in southeast Asia pacific region as Alleviare Life Sciences Limited.

We have shipped to:

We have delivered medicines to following countries – Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, India, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe.


All Trademarks and Brands that appear on the website belong to their respective owners. Alleviare provides only information & in any way, does not lay any claim on these brand names &/or trademarks.